Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Imaging in Pancreatic Cancer
NCT06144762Recruiting
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Dec 2023
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Integration of in vivo and ex vivo MRI with histology and molecular characteristics. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06144762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144762.